Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Trastornos del movimiento Movement disorders 321 artículos Viendo del 41 al 80 de 321 artículos
Pub MED

The functional roles of retromer in Parkinson's disease.NUEVO

Cui Y, Yang Z, Teasdale RD.
FEBS Lett. 2017 Dec 6. doi: 10.1002/1873-3468.12931. [Epub ahead of print] Review.
Pub MED

Effect of a Mat Pilates Program with TheraBand® on Dynamic Balance in Patients with Parkinson's Disease. Feasibility Study and Randomized Controlled Trial.NUEVO

Mollinedo I, Cancela JM, Vila Suarez MH.
Rejuvenation Res. 2017 Dec 5. doi: 10.1089/rej.2017.2007. [Epub ahead of print]
Pub MED

Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.NUEVO

Goldman JG, Andrews H, Amara A, Naito A, Alcalay RN, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, Saint-Hilaire MH, Frasier M, Arnedo V, Reimer AN, Sutherland M, Swanson-Fischer C, Gwinn K, Kang UJ.
Mov Disord. 2017 Dec 4. doi: 10.1002/mds.27232. [Epub ahead of print]
Pub MED

New drugs for Parkinson's disease: The regulatory and clinical development pathways in the United States.NUEVO

Kieburtz K, Katz R, Olanow CW.
Mov Disord. 2017 Dec 4. doi: 10.1002/mds.27220. [Epub ahead of print] No abstract available.
Pub MED

Beyond the lysosome: Cholesterol role on endoplasmic reticulum and lipid droplets in Parkinson's disease.NUEVO

Fernandes HJR.
Mov Disord. 2017 Dec 4. doi: 10.1002/mds.27249. [Epub ahead of print] No abstract available.
Pub MED

Analyzing gait variability and dual-task interference in patients with Parkinson's disease and freezing by means of the word-color Stroop test.NUEVO

Kleiner AFR, Pagnussat AS, Prisco GD, Vagnini A, Stocchi F, De Pandis MF, Galli M.
Aging Clin Exp Res. 2017 Dec 2. doi: 10.1007/s40520-017-0862-0. [Epub ahead of print]
Pub MED

Longitudinal Decline of Striatal Subregional [(18)F]FP-CIT Uptake in Parkinson's Disease.NUEVO

Sung C, Lee JH, Oh JS, Oh M, Lee SJ, Oh SJ, Chung SJ, Lee CS, Kim JS.
Nucl Med Mol Imaging. 2017 Dec;51(4):304-313. doi: 10.1007/s13139-017-0481-x. Epub 2017 Apr 6.
Pub MED

Glaucocalyxin B Alleviates Lipopolysaccharide-Induced Parkinson's Disease by Inhibiting TLR/NF-κB and Activating Nrf2/HO-1 Pathway.NUEVO

Xu W, Zheng D, Liu Y, Li J, Yang L, Shang X.
Cell Physiol Biochem. 2017 Dec 12;44(6):2091-2104. doi: 10.1159/000485947. [Epub ahead of print]
Pub MED

Ultrasound-triggered effects of the microbubbles coupled to GDNF- and Nurr1-loaded PEGylated liposomes in a rat model of Parkinson's disease.NUEVO

Yue P, Gao L, Wang X, Ding X, Teng J.
J Cell Biochem. 2017 Dec 14. doi: 10.1002/jcb.26608. [Epub ahead of print]
Pub MED

Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.NUEVO

Sarookhani MR, Haghdoost-Yazdi H, Sarbazi-Golezari A, Babayan-Tazehkand A, Rastgoo N.
Behav Pharmacol. 2017 Dec 12. doi: 10.1097/FBP.0000000000000358. [Epub ahead of print]
Pub MED

microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.NUEVO

Leggio L, Vivarelli S, L'Episcopo F, Tirolo C, Caniglia S, Testa N, Marchetti B, Iraci N.
Int J Mol Sci. 2017 Dec 13;18(12). pii: E2698. doi: 10.3390/ijms18122698. Review.
Pub MED

Autophagy impairment in Parkinson's disease.NUEVO

Karabiyik C, Lee MJ, Rubinsztein DC.
Essays Biochem. 2017 Dec 12;61(6):711-720. doi: 10.1042/EBC20170023. Print 2017 Dec 12. Review.
Pub MED

Post-Operative Stridor and Acute Respiratory Failure after Parkinson's disease Deep Brain Stimulator Placement - A Case Report and Review of Literature.NUEVO

Wang M, Saasouh W, Botsford T, Keebler A, Zura A, Benninger MS, Avitsian R.
World Neurosurg. 2017 Dec 8. pii: S1878-8750(17)32109-5. doi: 10.1016/j.wneu.2017.11.176. [Epub ahead of print]
Pub MED

Nicotine gum as a therapeutic approach for low blood pressure in Parkinson's disease: A randomized pilot study.NUEVO

DiFrancisco-Donoghue J, Jung MK, Leder A.
Nicotine Tob Res. 2017 Dec 1. doi: 10.1093/ntr/ntx263. [Epub ahead of print]
Pub MED

In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.NUEVO

Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, Teipel SJ, Grothe MJ.
Brain. 2017 Dec 8. doi: 10.1093/brain/awx310. [Epub ahead of print]
Pub MED

Effects of virtual rehabilitation versus conventional physical therapy on postural control, gait, and cognition of patients with Parkinson's disease: study protocol for a randomized controlled feasibility trial.NUEVO

Silva KG, De Freitas TB, Doná F, Ganança FF, Ferraz HB, Torriani-Pasin C, Pompeu JE.
Pilot Feasibility Stud. 2017 Dec 6;3:68. doi: 10.1186/s40814-017-0210-3. eCollection 2017.
Pub MED

Subthalamotomy for Parkinson's disease: clinical outcome and topography of lesions.NUEVO

Rodriguez-Rojas R, Carballo-Barreda M, Alvarez L, Guridi J, Pavon N, Garcia-Maeso I, Macías R, Rodriguez-Oroz MC, Obeso JA.
J Neurol Neurosurg Psychiatry. 2017 Dec 8. pii: jnnp-2017-316241. doi: 10.1136/jnnp-2017-316241. [Epub ahead of print]
Pub MED

Toward patient-centered outcomes for cognitive evaluations: the perspective of those affected by Parkinson's disease.NUEVO

Benge JF, Heemsbergen T, Nelson RA, Konesheck DO, Konesheck B, Aaron CS.
Clin Neuropsychol. 2017 Dec 20:1-16. doi: 10.1080/13854046.2017.1414884. [Epub ahead of print]
Pub MED

Neuroprotective effect of treadmill exercise possibly via regulation of lysosomal degradation molecules in mice with pharmacologically induced Parkinson's disease.NUEVO

Hwang DJ, Koo JH, Kwon KC, Choi DH, Shin SD, Jeong JH, Um HS, Cho JY.
J Physiol Sci. 2017 Dec 19. doi: 10.1007/s12576-017-0586-0. [Epub ahead of print]
Pub MED

Adaptation of Stability during Perturbed Walking in Parkinson's Disease.NUEVO

Martelli D, Luo L, Kang J, Kang UJ, Fahn S, Agrawal SK.
Sci Rep. 2017 Dec 19;7(1):17875. doi: 10.1038/s41598-017-18075-6.
Pub MED

Before and after the veterans affairs cooperative program 468 study: Deep brain stimulator target selection for treatment of Parkinson's disease.NUEVO

Southwell DG, Rutkowski MJ, San Luciano M, Racine C, Ostrem J, Starr PA, Larson PS.
Parkinsonism Relat Disord. 2017 Dec 12. pii: S1353-8020(17)30839-8. doi: 10.1016/j.parkreldis.2017.12.013. [Epub ahead of print]
Pub MED

Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease.NUEVO

De Rosa A, Peluso S, De Lucia N, Russo P, Annarumma I, Esposito M, Manganelli F, Brunetti A, De Michele G, Pappatà S.
Parkinsonism Relat Disord. 2017 Dec 9. pii: S1353-8020(17)30834-9. doi: 10.1016/j.parkreldis.2017.12.008. [Epub ahead of print]
Pub MED

Combined cardiovascular and sweating autonomic testing to differentiate multiple system atrophy from Parkinson's disease.NUEVO

Pavy-LeTraon A, Brefel-Courbon C, Dupouy J, Ory-Magne F, Rascol O, Senard JM.
Neurophysiol Clin. 2017 Dec 14. pii: S0987-7053(17)30203-4. doi: 10.1016/j.neucli.2017.11.003. [Epub ahead of print]
Pub MED

Targeting gait and life quality in persons with Parkinson's disease: Potential benefits of Equine-Assisted Interventions.NUEVO

Peppe A, Costa A, Cerino S, Caltagirone C, Alleva E, Borgi M, Cirulli F.
Parkinsonism Relat Disord. 2017 Dec 11. pii: S1353-8020(17)30829-5. doi: 10.1016/j.parkreldis.2017.12.003. [Epub ahead of print] No abstract available.
Pub MED

A Peek into Parkinson's Disease Progression through Human Dopamine Neurons in a Dish.NUEVO

Yang N, Yue Z.
Trends Neurosci. 2017 Dec 13. pii: S0166-2236(17)30235-7. doi: 10.1016/j.tins.2017.12.001. [Epub ahead of print]
Pub MED

Neurotrophin Expression in Lymphocytes: a Powerful Indicator of Degeneration in Parkinson's Disease, Amyotrophic Lateral Sclerosis and Ataxia.NUEVO

Sadanand A, Janardhanan A, Vanisree AJ, Pavai T.
J Mol Neurosci. 2017 Dec 16. doi: 10.1007/s12031-017-1014-x. [Epub ahead of print]
Pub MED

Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomal iron imaging in Parkinson's disease).NUEVO

Schwarz ST, Xing Y, Naidu S, Birchall J, Skelly R, Perkins A, Evans J, Sare G, Martin-Bastida A, Bajaj N, Gowland P, Piccini P, Auer DP.
BMJ Open. 2017 Dec 14;7(12):e016904. doi: 10.1136/bmjopen-2017-016904.
Pub MED

Sensory training with vibration-induced kinesthetic illusions improves proprioceptive integration in patients with Parkinson's disease.NUEVO

Ribot-Ciscar E, Aimonetti JM, Azulay JP.
J Neurol Sci. 2017 Dec 15;383:161-165. doi: 10.1016/j.jns.2017.11.016. Epub 2017 Nov 20.
Pub MED

A MDS-UPDRS Part II (motor experiences of daily living) score to predict recurrent falls in people with Parkinson's disease.NUEVO

Almeida LRS, Valenca GT, Oliveira-Filho J.
J Neurol Sci. 2017 Dec 15;383:114-115. doi: 10.1016/j.jns.2017.10.047. Epub 2017 Oct 28. No abstract available.
Pub MED

Parkinson's disease physiotherapy: specialisation adds value.NUEVO

Parashos SA.
Lancet Neurol. 2017 Dec 12. pii: S1474-4422(17)30437-4. doi: 10.1016/S1474-4422(17)30437-4. [Epub ahead of print] No abstract available.
Pub MED

Predictive risk factors for chronic low back pain in Parkinson's disease.NUEVO

Ozturk EA, Kocer BG.
Clin Neurol Neurosurg. 2017 Dec 11;164:190-195. doi: 10.1016/j.clineuro.2017.12.011. [Epub ahead of print]
Pub MED

Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study.NUEVO

Sommerauer M, Fedorova TD, Hansen AK, Knudsen K, Otto M, Jeppesen J, Frederiksen Y, Blicher JU, Geday J, Nahimi A, Damholdt MF, Brooks DJ, Borghammer P.
Brain. 2017 Dec 18. doi: 10.1093/brain/awx348. [Epub ahead of print]
Pub MED

Handwriting training in Parkinson's disease: A trade-off between size, speed and fluency.NUEVO

Nackaerts E, Broeder S, Pereira MP, Swinnen SP, Vandenberghe W, Nieuwboer A, Heremans E.
PLoS One. 2017 Dec 22;12(12):e0190223. doi: 10.1371/journal.pone.0190223. eCollection 2017.
Pub MED

Trichloroethylene and Parkinson's Disease: Risk Assessment.NUEVO

Liu M, Shin EJ, Dang DK, Jin CH, Lee PH, Jeong JH, Park SJ, Kim YS, Xing B, Xin T, Bing G, Kim HC.
Mol Neurobiol. 2017 Dec 22. doi: 10.1007/s12035-017-0830-x. [Epub ahead of print]
Pub MED

[Comparison of Parkinson's monkey models induced by unilateral and bilateral intracerebroventricular injections of MPP()].NUEVO

Li J, Zhang HY, Jiang Y, Li TQ.
Sheng Li Xue Bao. 2017 Dec 25;69(6):743-750. Chinese.
Pub MED

Altered emotional prosody processing in patients with Parkinson's disease after subthalamic nucleus stimulation.NUEVO

Jin Y, Mao Z, Ling Z, Xu X, Xie G, Yu X.
Neuropsychiatr Dis Treat. 2017 Dec 11;13:2965-2975. doi: 10.2147/NDT.S153505. eCollection 2017.
Pub MED

Magnetic Resonance Imaging-guided Focused Ultrasound Thalamotomy for Parkinson's Disease: A Case Report.NUEVO

Ito H, Fukutake S, Yamamoto K, Yamaguchi T, Taira T, Kamei T.
Intern Med. 2017 Dec 21. doi: 10.2169/internalmedicine.9586-17. [Epub ahead of print]
Pub MED

Reinforcing mitochondrial functions in aging brain: An insight into Parkinson's disease therapeutics.NUEVO

Chandra G, Shenoi RA, Anand R, Rajamma U, Mohanakumar KP.
J Chem Neuroanat. 2017 Dec 18. pii: S0891-0618(17)30122-9. doi: 10.1016/j.jchemneu.2017.12.004. [Epub ahead of print] Review.
Pub MED

Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients.NUEVO

Liguori C, Mercuri NB, Stefani A, Pierantozzi M.
Sleep Med. 2017 Dec 18. pii: S1389-9457(17)30376-3. doi: 10.1016/j.sleep.2017.09.017. [Epub ahead of print] No abstract available.
Pub MED

Biological Implications of Differential Expression of Mitochondrial-Shaping Proteins in Parkinson's Disease.NUEVO

Rocha S, Freitas A, Guimaraes SC, Vitorino R, Aroso M, Gomez-Lazaro M.
Antioxidants (Basel). 2017 Dec 21;7(1). pii: E1. doi: 10.3390/antiox7010001.
Viendo del 41 al 80 de 321 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.